Furthermore, m6A regulators, such as RBM15, METTL14 were also demonstrated to act as prognosis markers in multiple cancers, such as pancreatic cancer and hepatocellular carcinoma. This evidence concerns the gene METTL14 and pancreatic neoplasm.